VolitionRX (VNRX) Stock: Buy, Sell, or Hold?
VNRX - VolitionRX Limited Common Stock
$0.17
0.00 (-0.72%)
▼
5d:
-12.36%
30d:
-33.12%
90d:
-83.48%
WAIT
LOW Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Nov 12, 2026
20d
Get Alerted When VNRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: VNRX is down 12.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: VNRX is down 12.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: VNRX is currently trading at $0.17, which is considered oversold relative to its 30-day fair value range of $0.20 to $0.29. From a valuation perspective, the stock is trading at a discount (Forward PE: -0.2) compared to its historical average (0.6). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, VNRX is in a strong downtrend. The price is currently testing key support at $0.16. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: VNRX scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $13.62 (+8086.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, VNRX is in a strong downtrend. The price is currently testing key support at $0.16. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: VNRX scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $13.62 (+8086.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.20 -
$0.29
Company Quality Score
39/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
61.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 8086.3% below Wall St target ($13.62)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Composite score 39/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.20 -
$0.29
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.16
Resistance Level
$0.23
Current Trend
Strong Downtrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.20
Wall Street Target
$13.62
(+8086.3%)
Revenue Growth (YoY)
-2.0%
PE vs Historical
-0.2 vs 0.6
CHEAP
Share & Embed Analysis
Last updated: October 22, 2026 8:48 AM ET
Data refreshes hourly during market hours. Next update: 9:48 AM
Data refreshes hourly during market hours. Next update: 9:48 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VNRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
31 analysts |
$59 | 50 HOLD |
|
SYK
Stryker Corporation |
STRONG BUY
29 analysts |
$363 | 37 SELL |
|
MDT
Medtronic PLC |
BUY
29 analysts |
$105 | 43 HOLD |
|
AXGN
Axogen Inc |
STRONG BUY
12 analysts |
$54 | 75 BUY |
|
TNDM
Tandem Diabetes Care Inc |
BUY
25 analysts |
$28 | 54 HOLD |
